AUPH
Aurinia Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$16.08
−0.25%Leverage
- Debt / equity
- 0.10x
- Net debt / equity
- -0.19x
- Debt / assets
- 0.08x
- Debt / EBITDA
- 0.32x
- Net debt / EBITDA
- -0.63x
Liquidity & coverage
- Current ratio
- 5.42x
- Quick ratio
- 4.97x
- Cash ratio
- 4.44x
- Interest coverage
- 17.79x
- EBITDA / interest
- 22.21x
- Working capital
- $441.4M
Cash & dividend
- FCF / debt
- 2.87x
- Cash flow / debt
- 2.88x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026